Increased lymphoma risk in patients with systemic manifestations of Sjögren’s disease: a population-based study - Summary - MDSpire

Increased lymphoma risk in patients with systemic manifestations of Sjögren’s disease: a population-based study

  • By

  • Teresa Blázquez-Sánchez

  • Arantxa Torres-Roselló

  • Javier Llorca

  • Jorge Mairal-Monesma

  • Otto Olivas-Vergara

  • Raquel Largo

  • Esperanza Naredo

  • Miguel Ángel González-Gay

  • May 29, 2026

  • 0 min

Share

Objective:

To assess clinical and immunological characteristics, disease activity, and lymphoma development in patients with Sjögren’s disease, focusing on differences between glandular and systemic phenotypes.

Key Findings:
  • Lymphoma occurred in 5% of patients, predominantly non-Hodgkin lymphoma in the systemic group (10% vs. 1%; p = 0.001).
Interpretation:

Remove the interpretation section.

Limitations:
  • Retrospective design may limit the ability to establish causation.
  • Single-center study may affect generalizability of findings.
Conclusion:

Remove the conclusion section.

Original Source(s)

Increased lymphoma risk in patients with systemic manifestations of Sjögren’s disease: a population-based study

  • by Teresa Blázquez-Sánchez, Arantxa Torres-Roselló, Javier Llorca, Jorge Mairal-Monesma, Otto Olivas-Vergara, Raquel Largo, Esperanza Naredo, Miguel Ángel González-Gay

  • May 29, 2026

Related Content

Liver steatosis, selected organokines, and cardiovascular risk markers in rheumatoid arthritis

Successful treatment of refractory focal eosinophilic myositis with extra-ocular muscle involvement using tocilizumab: a case report

Correction: Roles of exosomal non-coding RNAs in osteoarthritis